Clozapine is the most effective antipsychotic for patients with treatment-resistant schizophrenia. However, response is highly variable and possible genetic underpinnings of this variability remain unknown. Here, we performed polygenic risk score (PRS) analyses to estimate the amount of variance in symptom severity among clozapine-treated patients explained by PRSs (R2) and examined the association between symptom severity and genotype-predicted CYP1A2, CYP2D6, and CYP2C19 enzyme activity. Genome-wide association (GWA) analyses were performed to explore loci associated with symptom severity. A multicenter cohort of 804 patients (after quality control N = 684) with schizophrenia spectrum disorder treated with clozapine were cross-sectionally assessed using the Positive and Negative Syndrome Scale and/or the Clinical Global Impression-Severity (CGI-S) scale. GWA and PRS regression analyses were conducted. Genotype-predicted CYP1A2, CYP2D6, and CYP2C19 enzyme activities were calculated. Schizophrenia-PRS was most significantly and positively associated with low symptom severity (p = 1.03 × 10−3; R2 = 1.85). Cross-disorder-PRS was also positively associated with lower CGI-S score (p = 0.01; R2 = 0.81). Compared to the lowest tertile, patients in the highest schizophrenia-PRS tertile had 1.94 times (p = 6.84×10−4) increased probability of low symptom severity. Higher genotype-predicted CYP2C19 enzyme activity was independently associated with lower symptom severity (p = 8.44×10−3). While no locus surpassed the genome-wide significance threshold, rs1923778 within NFIB showed a suggestive association (p = 3.78×10−7) with symptom severity. We show that high schizophrenia-PRS and genotype-predicted CYP2C19 enzyme activity are independently associated with lower symptom severity among individuals treated with clozapine. Our findings open avenues for future pharmacogenomic projects investigating the potential of PRS and genotype-predicted CYP-activity in schizophrenia.
Rumination, characterized by repetitive and passive thinking, is examined in this study in relation to psychological resilience among physicians exposed to occupational stressors that can affect their mental health. Understanding the factors that contribute to resilience in this population is crucial for effectively addressing mental health challenges within the medical community. A total of 205 physicians completed an online survey including sociodemographic questions and validated measures of rumination, perceived stress, and resilience. Data were analyzed using descriptive statistics, group comparisons, correlation, regression, and moderation analyses. Higher levels of perceived stress and rumination were associated with lower resilience. Regression analyses indicated that both variables were independently associated with resilience. The moderation model showed that rumination did not significantly moderate the relationship between perceived stress and resilience. Participants with current psychiatric diagnoses or suicidal ideation reported higher perceived stress and lower resilience. Those reporting greater satisfaction with their work and social life reported lower levels of stress and rumination and higher resilience. Female physicians reported significantly higher perceived stress and lower resilience compared to males; however, there was no statistically significant gender difference in rumination. Interventions aimed at reducing stress and targeting maladaptive rumination (e.g., rumination-focused therapies, digital health tools) may help protect psychological well-being, particularly in high-risk groups such as female physicians or those with mental health difficulties. Future longitudinal and prospective studies are needed to clarify the temporal relationships among stress, rumination, and resilience.
Aim : Both general medical and mental health services were disrupted during the pandemic. It is unclear how these disruptions played out for people with various mental health diagnoses. We compared change in mental health status and use of mental health services between four psychiatric groups: schizophrenia spectrum disorders, bipolar disorder, unipolar depression, and anxiety/obsessive-compulsive disorder (OCD). Method : Using a semi-structured interview, 492 psychiatric outpatients who had used psychiatric services of a university hospital before the pandemic were assessed on the phone during the pandemic. Results : About half of the sample reported a perceived need for contact with mental health services during the pandemic, half of whom actually used services. Need for contact was much lower in the schizophrenia group than other diagnostic groups, whereas actual use of services was lower in the unipolar depression and anxiety/OCD groups. Conclusions : Patients with severe mental disorders, such as schizophrenia or bipolar disorders, may not have been more disadvantaged than those with anxiety/depression spectrum disorders during the pandemic. The pandemic response structure of mental health services should be modified to fit the needs of anxiety/depression spectrum patients.